|
All Routes of Administration - Regulatory guidelines require that pharmaceutical and biopharmaceutical products, which will be administered to humans for a period of longer than six months undergo carcinogenicity testing. ITR Canada offers conventional two-year carcinogenicity studies in both rats and mice as well as 26 week studies in transgenic mice. Continue on to Conventional Carcinogenicity Studies |
